The Public Cannabis Company Revenue & Income Tracker gives investors a clear, data-driven view of earnings across the sector. In an industry that shifts rapidly, precise financial tracking matters because outcomes hinge on regulatory and market changes. Q4 financials often reveal momentum or stress, and therefore they shape investor decisions. As a result, missing a small revenue trend can mean missing a large investment signal. Moreover, the tracker ranks top revenue producing companies using SEC and SEDAR filings to ensure factual comparability.
This introduction previews a detailed revenue tracker and earnings analysis for major cannabis firms. It includes Q4 results, GAAP and IFRS notes, and adjusted operating income. Because many companies moved accounting standards recently, readers must pay attention to reporting changes. The piece highlights thresholds, senior and junior lists, and notable movers like Tilray and Vireo Growth. Finally, the goal is to equip traders and investors with clear numbers, actionable context, and next steps for portfolio decisions.
Public Cannabis Company Revenue & Income Tracker
The Public Cannabis Company Revenue & Income Tracker collects and ranks reported revenue for major cannabis companies. It pulls numbers from quarterly SEC and SEDAR filings, and therefore it focuses on actual reported revenue. For more background and updates visit New Cannabis Ventures. For Canadian filings see SEDAR Plus. The tracker excludes pro forma revenue and highlights accounting moves from IFRS to U.S. GAAP.
Investors and industry watchers rely on this tracker because it turns raw filings into clear signals. It shows who grows revenue and who lags. As a result, traders can compare industry earnings and spot shifts in the stock market cannabis space. Moreover, analysts use the tracker to test valuation assumptions and stress test models.
Key insights the tracker provides
- Ranked revenue by quarter so you can see momentum and trend changes quickly
- Adjusted operating income and segment details to separate cannabis financial data from non cannabis operations
- Minimum revenue thresholds clarifying which firms qualify for senior or junior lists
- Currency and accounting notes to account for USD and CAD reporting differences
- Real reported revenue only, not pro forma, improving comparability
Currently the senior list includes 19 companies and the junior list includes 11, based on minimum revenue thresholds. Notable movers include Tilray, Vireo Growth, and Organigram, which demonstrate how listings shift. Therefore, the tracker helps monitor structural industry changes.
Use the tracker to inform watchlists and model updates. Finally, combine its data with earnings calls and market context to make better decisions.
| Company | Fiscal year | Revenue | Net income (loss) | Source |
|---|---|---|---|---|
| Tilray Brands | FY2024 | $788.9 million USD | – $222.4 million USD | Source |
| Curaleaf Holdings | FY2024 | $1.34 billion USD | – $216.2 million USD | Source |
| Green Thumb Industries | FY2024 | $1.137 billion USD | $73.1 million USD | Source |
| Canopy Growth | FY2024 | C$297.1 million CAD | -C$229 million CAD | Source |
Trends and Challenges for the Public Cannabis Company Revenue & Income Tracker
The Public Cannabis Company Revenue & Income Tracker highlights recent revenue trends and mounting headwinds for public operators. Many firms show slower top line growth and inconsistent profitability. For example, Statistics Canada reported total legal cannabis sales of C$5.5 billion for April 2024 to March 2025. See the full report at Statistics Canada Report.
However, regulatory shifts and market volatility create clear challenges for revenue and income. Rising debt maturities pressure balance sheets, and refinancing risk affects capital allocation. Moreover, accounting transitions from IFRS to U.S. GAAP change comparability across filings. New Cannabis Ventures notes deteriorating financial positions at many public firms, which compounds investor caution. See New Cannabis Ventures Report and Tilray Q3 Coverage.
As a result, the tracker helps investors spot leader laggard divergence in the stock market cannabis sector. It also shows which companies depend on non cannabis segments for operating profit. Therefore, combine tracker data with earnings calls and debt schedules to assess risk. In short, tracking actual reported revenue remains essential because it exposes real operational momentum and financial strain.
The Public Cannabis Company Revenue & Income Tracker distills quarterly filings into clear, comparable metrics. It lets investors see revenue momentum and profit trends fast. Because filings vary, the tracker enforces consistent thresholds and reporting rules.
Therefore analysts use it to gauge company health and market momentum. It highlights which firms rely on cannabis operations versus other segments. EMP0 also provides supplemental feeds and alerting for real time monitoring. However, the tracker remains the primary source for reconciled revenue and income.
As a result, traders can update valuations, adjust risk, and set watchlists. Use the tracker with earnings calls and debt schedules for deeper insight. MyCBDAdvisor supports clear, trustworthy cannabinoid information and data driven tools. Visit MyCBDAdvisor to learn more about our mission and resources.
Ultimately, the tracker equips investors with factual signals instead of noise. It reduces guesswork and exposes both growth and distress quickly. Finally, combine the tracker, EMP0 alerts, and company filings for disciplined decision making. We aim to make cannabis finance accessible.
Frequently Asked Questions (FAQs)
What is the Public Cannabis Company Revenue & Income Tracker?
The Public Cannabis Company Revenue & Income Tracker compiles reported revenue and operating income for public cannabis firms. It ranks companies by quarterly results. The tracker focuses on actual reported numbers, not pro forma figures.
How do I use the tracker?
– Scan ranked lists to spot leaders and laggards.
– Compare quarter to quarter revenue and adjusted operating income.
– Use filters for USD or CAD reporting and senior or junior lists.
These steps help you track cannabis financial data and industry earnings.
Where does the data come from?
The tracker uses SEC and SEDAR filings and company quarterly reports because filings provide audited details. It also requires segment disclosures when firms report non cannabis operations. Therefore it ensures comparability across filings.
How accurate is the tracker?
The tracker relies on filed statements, so accuracy equals company disclosures. However accounting shifts from IFRS to U.S. GAAP can affect comparability. As a result, users should read notes and management commentary. The tracker is not investment advice.
How often is it updated?
The tracker updates after each quarterly filing. Moreover New Cannabis Ventures refreshes minimum thresholds periodically. For real time alerts, combine the tracker with EMP0 feeds or earnings call coverage.
